[1]CurrentPatentAssignee:CHONGQINGKERUIPHARMACEUTICALGROUP-CN103896938,2016,BLocationinpatent:Paragraph0066
[2]Naito,Ryo;Yonetoku,Yasuhiro;Okamoto,Yoshinori;Toyoshima,Akira;Ikeda,Ken;Takeuchi,Makoto[JournalofMedicinalChemistry,2005,vol.48,#21,p.6597-6606]
[3]Ye,Zhi-Shi;Guo,Ran-Ning;Cai,Xian-Feng;Chen,Mu-Wang;Shi,Lei;Zhou,Yong-Gui[AngewandteChemie-InternationalEdition,2013,vol.52,#13,p.3685-3689][Angew.Chem.,2013,vol.125,#13,p.3773-3777,5]
[4]Babu,R.Anji;Reddy,N.SivaSenkar;Reddy,B.JaganMohan;Reddy,B.V.Subba[Synthesis,2014,vol.46,#20,p.2794-2798]
[5]CurrentPatentAssignee:ShanghaiInstituteofMateriaMedica(in:CAS);CHINESEACADEMYOFSCIENCES-CN108203434,2018,ALocationinpatent:Paragraph0172;0173;0174
[6]CurrentPatentAssignee:ZYDUSLIFESCIENCESLTD-WO2009/87664,2009,A1Locationinpatent:Page/Pagecolumn26
[7]CurrentPatentAssignee:ADVENTINTERNATIONALCORPORATION-US2009/203914,2009,A1Locationinpatent:Page/Pagecolumn3
[8]CurrentPatentAssignee:ADVENTINTERNATIONALCORPORATION-US2009/203914,2009,A1Locationinpatent:Page/Pagecolumn3
[9]CurrentPatentAssignee:ADVENTINTERNATIONALCORPORATION-US2009/203914,2009,A1Locationinpatent:Page/Pagecolumn3-4
[10]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2008/11462,2008,A2Locationinpatent:Page/Pagecolumn23;24
[11]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2009/11844,2009,A1Locationinpatent:Page/Pagecolumn16
[12]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2009/11844,2009,A1Locationinpatent:Page/Pagecolumn16-17;21;21-22;22-23
[13]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2009/11844,2009,A1Locationinpatent:Page/Pagecolumn17
[14]CurrentPatentAssignee:KRKADDNOVOMESTO-WO2010/12459,2010,A2Locationinpatent:Page/Pagecolumn33-34
[15]CurrentPatentAssignee:ADVENTINTERNATIONALCORPORATION-US2010/145055,2010,A1Locationinpatent:Page/Pagecolumn3
[16]CurrentPatentAssignee:CURIAINC-WO2012/4264,2012,A1Locationinpatent:Page/Pagecolumn17-18
[17]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2008/128028,2008,A2Locationinpatent:Page/Pagecolumn30
[1]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2008/11462,2008,A2Locationinpatent:Page/Pagecolumn22;23
[1]CurrentPatentAssignee:ADVENTINTERNATIONALCORPORATION-WO2008/77357,2008,A2Locationinpatent:Page/Pagecolumn5-6
[2]CurrentPatentAssignee:ADVENTINTERNATIONALCORPORATION-US2010/145055,2010,A1Locationinpatent:Page/Pagecolumn3
[3]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2008/11462,2008,A2Locationinpatent:Page/Pagecolumn25
[4]CurrentPatentAssignee:KRKADDNOVOMESTO-WO2010/12459,2010,A2Locationinpatent:Page/Pagecolumn38-39
[1]Naito,Ryo;Yonetoku,Yasuhiro;Okamoto,Yoshinori;Toyoshima,Akira;Ikeda,Ken;Takeuchi,Makoto[JournalofMedicinalChemistry,2005,vol.48,#21,p.6597-6606]
[2]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2008/128028,2008,A2
[1]Naito,Ryo;Yonetoku,Yasuhiro;Okamoto,Yoshinori;Toyoshima,Akira;Ikeda,Ken;Takeuchi,Makoto[JournalofMedicinalChemistry,2005,vol.48,#21,p.6597-6606]
[2]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-WO2008/128028,2008,A2
Title: Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
Journal: Expert opinion on drug metabolism & toxicology 20121101
Title: ACP Journal Club. Review: drugs for urgency urinary incontinence improve continence in women.
Journal: Annals of internal medicine 20121016
Title: Are solifenacin and ramosetron really ideal to treat irritable bowel syndrome?
Journal: Journal of neurogastroenterology and motility 20121001
Title: Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply.
Journal: Journal of neurogastroenterology and motility 20121001
Title: Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: an open-label, multicenter, prospective study.
Journal: Neurourology and urodynamics 20120901
Title: Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.
Journal: International neurourology journal 20120901
Title: Solifenacin for overactive bladder: a systematic review and meta-analysis.
Journal: International urogynecology journal 20120801
Title: Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial.
Journal: Journal of neurogastroenterology and motility 20120701
Title: Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.
Journal: Annals of internal medicine 20120619
Title: Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome.
Journal: World journal of urology 20120601
Title: Practical consensus guidelines for the management of enuresis.
Journal: European journal of pediatrics 20120601
Title: Has the cost of anti-muscarinic a key role in the success rate of patients diagnosed with overactive bladder syndrome?
Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20120601
Title: Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome.
Journal: International urology and nephrology 20120401
Title: Re: Tadalafil Versus Solifenacin for Persistent Storage Symptoms After Prostate Surgery in Patients With Erectile Dysfunction: A Prospective Randomized Study.
Journal: The Journal of urology 20120401
Title: Efficacy and safety of propiverine in children with overactive bladder.
Journal: Korean journal of urology 20120401
Title: Improvement of urinary dysfunction after kidney transplantation by administration of the antimuscarinic agent--prospective randomized controlled study.
Journal: Transplantation 20120327
Title: The Relations between Enuresis in Childhood and Nocturnal Polyuria Syndrome in Adult Life.
Journal: International neurourology journal 20120301
Title: The efficacy and safety of solifenacin in patients with overactive bladder syndrome.
Journal: Collegium antropologicum 20120301
Title: Which anticholinergic drug for overactive bladder symptoms in adults.
Journal: The Cochrane database of systematic reviews 20120118
Title: Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation.
Journal: The journal of physical chemistry. B 20120112
Title: Neurogenic bladder.
Journal: Advances in urology 20120101
Title: Efficacy of solifenacin for overactive bladder symptoms, symptom bother, and health-related quality of life in patients by duration of self-reported symptoms: a secondary analysis of the VIBRANT study.
Journal: Urologic nursing 20120101
Title: Adding to the evidence base: efficacy of solifenacin for overactive bladder symptoms, symptom bother, and health-related quality of life in patients by duration of self-reported symptoms: a secondary analysis of the VIBRANT study.
Journal: Urologic nursing 20120101
Title: An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects.
Journal: British journal of clinical pharmacology 20111201
Title: Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
Journal: International journal of urology : official journal of the Japanese Urological Association 20111201
Title: Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
Journal: Urology 20111201
Title: Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
Journal: Neurourology and urodynamics 20111101
Title: Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.
Journal: Current urology reports 20111001
Title: Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex.
Journal: The Journal of pharmacology and experimental therapeutics 20111001
Title: [Treatment for overactive bladder].
Journal: Der Urologe. Ausg. A 20111001
Title: Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance.
Journal: Urology 20110901
Title: In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20110901
Title: Montelukast for symptom control of interstitial cystitis.
Journal: The Annals of pharmacotherapy 20110901
Title: [Intravesical therapy of heparin and lidocaine for interstitial cystitis : a case report].
Journal: Hinyokika kiyo. Acta urologica Japonica 20110901
Title: Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation.
Journal: International neurourology journal 20110901
Title: Efficacy of anticholinergics for chronic prostatitis/chronic pelvic pain syndrome in young and middle-aged patients: a single-blinded, prospective, multi-center study.
Journal: International neurourology journal 20110901
Title: α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.
Journal: British journal of clinical pharmacology 20110801
Title: A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.
Journal: British journal of clinical pharmacology 20110801
Title: The effect of solifenacin on urethral sphincter morphology.
Journal: International urogynecology journal 20110801
Title: Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome.
Journal: The journal of obstetrics and gynaecology research 20110801
Title: Species independence in brain tissue binding using brain homogenates.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110701
Title: A semiphysiological population model for prediction of the pharmacokinetics of drugs under liver and renal disease conditions.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110701
Title: Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary.
Journal: The Journal of urology 20110701
Title: Tadalafil versus solifenacin for persistent storage symptoms after prostate surgery in patients with erectile dysfunction: a prospective randomized study.
Journal: International journal of urology : official journal of the Japanese Urological Association 20110701
Title: Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study.
Journal: Urology 20110701
Title: Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events?
Journal: Journal of the American Geriatrics Society 20110701
Title: Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts.
Journal: Korean journal of urology 20110701
Title: Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.
Journal: Bioorganic & medicinal chemistry letters 20110601
Title: Effect of desmopressin with anticholinergics in female patients with overactive bladder.
Journal: Korean journal of urology 20110601
Title: Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.
Journal: International journal of clinical practice 20110401
Title: Which single-item measures of overactive bladder symptom treatment correlate best with patient satisfaction?
Journal: Neurourology and urodynamics 20110401
Title: Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.
Journal: Korean journal of urology 20110401
Title: Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.
Journal: Journal of the American Geriatrics Society 20110301
Title: Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (≤ 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study.
Journal: Current medical research and opinion 20110201
Title: Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study.
Journal: International journal of clinical practice 20110201
Title: [Treatment with solifenacin reduces urinary urgency and improves quality of life. Results of the non-interventional CAP-study].
Journal: MMW Fortschritte der Medizin 20110113
Title: Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.
Journal: Digestive diseases and sciences 20110101
Title: Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score.
Journal: Urology 20110101
Title: Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.
Journal: Postgraduate medicine 20110101
Title: Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.
Journal: Korean journal of urology 20110101
Title: Are antimuscarinic drugs effective against urinary frequency mediated by atropine-resistant contractions?
Journal: Journal of pharmacological sciences 20110101
Title: Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach.
Journal: PloS one 20110101
Title: Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model.
Journal: BMC urology 20110101
Title: An overview of the clinical use of antimuscarinics in the treatment of overactive bladder.
Journal: Advances in urology 20110101
Title: Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study.
Journal: Advances in urology 20110101
Title: The efficacy and safety of propiverine hydrochloride in patients with overactive bladder symptoms who poorly responded to previous anticholinergic agents.
Journal: Advances in urology 20110101
Title: [Impact of overactive bladder on sexual function in women].
Journal: Urologia 20110101
Title: Overactive bladder: the importance of tailoring treatment to the individual patient.
Journal: Journal of multidisciplinary healthcare 20110101
Title: Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis.
Journal: Neurology research international 20110101
Title: Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study).
Journal: Advances in urology 20110101
Title: Tolerance of bladder antispasmodics in children with urinary incontinence: An observational study from North India.
Journal: Indian journal of pharmacology 20110101
Title: Efficacy of Solifenacin on Overactive Bladder Symptoms, Symptom Bother, and Other Patient-Reported Outcomes in Subjects With or Without Incontinence: A Post Hoc Analysis of Data From VIBRANT.
Journal: Female pelvic medicine & reconstructive surgery 20110101
Title: Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study?
Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20101201
Title: Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101201
Title: Pregnancy in woman with spinal cord stimulator for complex regional pain syndrome: a case report and review of the literature.
Journal: The Korean journal of pain 20101201
Title: A validated rapid stability-indicating method for the determination of related substances in solifenacin succinate by ultra-fast liquid chromatography.
Journal: Journal of chromatographic science 20101101
Title: Efficacy of Solifenacin on Symptom Bother and Health-Related Quality of Life in Patients With Acute, Early Chronic, and Late Chronic Overactive Bladder: Secondary Analysis of Data From the VOLT Study.
Journal: Female pelvic medicine & reconstructive surgery 20101101
Title: Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
Journal: Current medical research and opinion 20101001
Title: Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis.
Journal: Urology 20101001
Title: Prospective open label study of solifenacin for overactive bladder in children.
Journal: The Journal of urology 20101001
Title: Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi 20101001
Title: Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder.
Journal: International journal of urology : official journal of the Japanese Urological Association 20100901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100901
Title: The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
Journal: BJU international 20100801
Title: The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
Journal: BJU international 20100801
Title: Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.
Journal: International urogynecology journal 20100701
Title: AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.
Journal: British journal of pharmacology 20100701
Title: New strategies for medical management of overactive bladder in children.
Journal: Current opinion in urology 20100701
Title: Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male 20100601
Title: Therapy: Solifenacin causes less dry mouth than oxybutynin in OAB.
Journal: Nature reviews. Urology 20100601
Title: Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.
Journal: The Journal of urology 20100501
Title: Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study.
Journal: BJU international 20100401
Title: Solifenacin: scientific evidence in the treatment of overactive bladder.
Journal: Archivos espanoles de urologia 20100401
Title: Pediatrics: combining antimuscarinics shows promise for overactive bladder.
Journal: Nature reviews. Urology 20100201
Title: Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia.
Journal: Current opinion in urology 20100101
Title: The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: bladder selectivity based on in vivo drug-receptor binding characteristics of antimuscarinic agents for treatment of overactive bladder.
Journal: Journal of pharmacological sciences 20100101
Title: The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes.
Journal: Journal of pharmacological sciences 20100101
Title: Solifenacin pharmacology.
Journal: Archivos espanoles de urologia 20100101
Title: Functional role of cannabinoid receptors in urinary bladder.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20100101
Title: Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents.
Journal: Quality in primary care 20100101
Title: Canadian cost-effectiveness analysis of solifenacin compared to oxybutynin immediate-release in patients with overactive bladder.
Journal: Journal of medical economics 20100101
Title: [Solifenacin in treatment of the overactive bladder syndrome--diagnosis, clinical management and results].
Journal: Akusherstvo i ginekologiia 20100101
Title: Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence.
Journal: BMC urology 20100101
Title: Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro.
Journal: International journal of chronic obstructive pulmonary disease 20100101
Title: Medical management of overactive bladder.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20100101
Title: [Treatment of overactive urinary bladder with imperative urinary incontinence in women].
Journal: Urologiia (Moscow, Russia : 1999) 20100101
Title: The add-on effect of solifenacin for patients with remaining overactive bladder after treatment with tamsulosin for lower urinary tract symptoms suggestive of benign prostatic obstruction.
Journal: Advances in urology 20100101
Title: Etiopathogenesis and management of bladder dysfunction in patients with posterior urethral valves.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20100101
Title: Bladder dysfunction in diabetes mellitus.
Journal: Frontiers in pharmacology 20100101
Title: Basic mechanisms of urgency: roles and benefits of pharmacotherapy.
Journal: World journal of urology 20091201
Title: Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.
Journal: The Journal of urology 20091201
Title: Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial.
Journal: International journal of clinical practice 20091201
Title: Treatment of dysautonomia associated with Parkinson's disease.
Journal: Parkinsonism & related disorders 20091201
Title: Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis.
Journal: The American journal of geriatric pharmacotherapy 20091201
Title: Anticholinergic drug use for overactive bladder in Sweden: a nationwide pharmacoepidemiological study.
Journal: International urogynecology journal and pelvic floor dysfunction 20091101
Title: Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
Journal: Expert opinion on drug safety 20091101
Title: Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome.
Journal: BJU international 20091001
Title: Solifenacin for therapy resistant overactive bladder.
Journal: The Journal of urology 20091001
Title: Double anticholinergic therapy for refractory overactive bladder.
Journal: The Journal of urology 20091001
Title: Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial.
Journal: Postgraduate medicine 20090901
Title: Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
Journal: European journal of pharmacology 20090801
Title: A systematic evaluation of factors associated with nocturia--the population-based FINNO study.
Journal: American journal of epidemiology 20090801
Title: Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.
Journal: International journal of clinical practice 20090801
Title: Tolterodine extended release is well tolerated in older subjects.
Journal: International journal of clinical practice 20090801
Title: Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacin.
Journal: International urogynecology journal and pelvic floor dysfunction 20090601
Title: Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Journal: The Journal of pharmacology and experimental therapeutics 20090301
Title: [Anticholinergic treatment of overactive bladder syndrome. Is it all the same?].
Journal: Der Urologe. Ausg. A 20090301
Title: Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
Journal: European journal of pharmacology 20090301
Title: In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
Journal: British journal of pharmacology 20090301
Title: Solifenacin succinate for the treatment of overactive bladder.
Journal: Expert opinion on drug metabolism & toxicology 20090301
Title: Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation.
Journal: Journal of medical economics 20090301
Title: Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
Journal: BJU international 20090201
Title: Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.
Journal: Neurourology and urodynamics 20090101
Title: The cost utility of solifenacin in the treatment of overactive bladder.
Journal: International urology and nephrology 20090101
Title: Treatment with solifenacin increases warning time and improves symptoms of overactive bladder: results from VENUS, a randomized, double-blind, placebo-controlled trial.
Journal: Urology 20090101
Title: Muscarinic receptor antagonists for overactive bladder treatment: does one fit all?
Journal: Current opinion in urology 20090101
Title: Solifenacin for overactive bladder in women unsuccessfully treated with immediate release oxybutynin: a pilot study.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20090101
Title: Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
Journal: Clinical drug investigation 20090101
Title: Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries.
Journal: Acta obstetricia et gynecologica Scandinavica 20090101
Title: The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.
Journal: Clinical interventions in aging 20090101
Title: Clinical pharmacokinetics and pharmacodynamics of solifenacin.
Journal: Clinical pharmacokinetics 20090101
Title: A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder.
Journal: BMC medical research methodology 20090101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090101
Title: Response to 'Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection'.
Journal: Drug metabolism and pharmacokinetics 20090101
Title: Oxybutynin extended release for the management of overactive bladder: a clinical review.
Journal: Drug design, development and therapy 20090101
Title: Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.
Journal: BMC urology 20090101
Title: Fesoterodine for the treatment of urinary incontinence and overactive bladder.
Journal: Therapeutics and clinical risk management 20090101
Title: Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction.
Journal: Advances in urology 20090101
Title: The symptomatic management of multiple sclerosis.
Journal: Annals of Indian Academy of Neurology 20090101
Title: Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective alpha1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081215
Title: QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.
Journal: British journal of clinical pharmacology 20081201
Title: [Efficacy and safety of solifenacin in daily clinical practice--clinical study phase IV].
Journal: Ceska gynekologie 20081201
Title: Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro.
Journal: International journal of chronic obstructive pulmonary disease 20081201
Title: Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.
Journal: International journal of clinical practice 20081101
Title: Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy.
Journal: International journal of clinical practice 20081101
Title: Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
Journal: BJU international 20081101
Title: Solifenacin at 3 years: a review of efficacy and safety. Commentary.
Journal: Postgraduate medicine 20081101
Title: [Economic impact of overactive bladder symptoms in Japan].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20081101
Title: Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.
Journal: International journal of clinical practice 20081101
Title: Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity.
Journal: International urogynecology journal and pelvic floor dysfunction 20081001
Title: Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
Journal: Clinical therapeutics 20081001
Title: The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.
Journal: European urology 20080901
Title: Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin.
Journal: Clinical interventions in aging 20080901
Title: Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20080801
Title: A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
Journal: Current medical research and opinion 20080801
Title: [Urinary urgency].
Journal: MMW Fortschritte der Medizin 20080731
Title: Solifenacin at 3 years: a review of efficacy and safety.
Journal: Postgraduate medicine 20080701
Title: In vivo quantitative autoradiographic analysis of brain muscarinic receptor occupancy by antimuscarinic agents for overactive bladder treatment.
Journal: The Journal of pharmacology and experimental therapeutics 20080601
Title: Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.
Journal: Current medical research and opinion 20080601
Title: [Overactive bladder. When it's pressing, immediate help is indicated].
Journal: MMW Fortschritte der Medizin 20080515
Title: Photodistributed lichenoid drug eruption secondary to solifenacin.
Journal: Clinical and experimental dermatology 20080501
Title: Urgency in overactive bladder: translating experimental data into clinical practice.
Journal: Drugs of today (Barcelona, Spain : 1998) 20080501
Title: Is solifenacin succinate safe and effective for the treatment of overactive bladder?
Journal: Nature clinical practice. Urology 20080301
Title: A simple validated scale to measure urgency.
Journal: The Journal of urology 20080301
Title: Solifenacin-induced small bowel pseudo-obstruction.
Journal: Journal of hospital medicine 20080301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080301
Title: A review of solifenacin in the treatment of urinary incontinence.
Journal: Therapeutics and clinical risk management 20080201
Title: Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial.
Journal: International journal of clinical practice 20080101
Title: Pharmacological analysis of the interaction of antimuscarinic drugs at M(2) and M(3) muscarinic receptors in vivo using the pithed rat assay.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20080101
Title: [Anticholinergic drugs in overactive bladder].
Journal: Gynecologie, obstetrique & fertilite 20080101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080101
Title: Pharmacological effects of solifenacin on human isolated urinary bladder.
Journal: Pharmacology 20080101
Title: Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study.
Journal: Drug safety 20080101
Title: Gateways to clinical trials. July-August 2008.
Journal: Methods and findings in experimental and clinical pharmacology 20080101
Title: [Assessment of symptoms severity in patients with overactive bladder].
Journal: Urologiia (Moscow, Russia : 1999) 20080101
Title: Practical management of nocturia in urology.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20080101
Title: Effects of intravenously and orally administered solifenacin succinate (YM905) on carbachol-induced intravesical pressure elevation and salivary secretion in mice.
Journal: Biological & pharmaceutical bulletin 20071201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071201
Title: Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071115
Title: Muscarinic receptor antagonists for overactive bladder.
Journal: BJU international 20071101
Title: Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Journal: European journal of pharmacology 20071031
Title: An unusual cause of postoperative detrusor overactivity.
Journal: International urogynecology journal and pelvic floor dysfunction 20071001
Title: Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.
Journal: European urology 20071001
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071001
Title: Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride.
Journal: International urogynecology journal and pelvic floor dysfunction 20070901
Title: Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
Journal: BJU international 20070901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20070901
Title: Pharmacologic management of overactive bladder.
Journal: Clinical interventions in aging 20070901
Title: Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials.
Journal: European urology 20070801
Title: Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms.
Journal: International urogynecology journal and pelvic floor dysfunction 20070701
Title: Overactive bladder treatments in early phase clinical trials.
Journal: Expert opinion on investigational drugs 20070701
Title: Agents for treatment of overactive bladder: a therapeutic class review.
Journal: Proceedings (Baylor University. Medical Center) 20070701
Title: Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?
Journal: BJU international 20070601
Title: Update on drugs for overactive bladder syndrome.
Journal: Drug and therapeutics bulletin 20070601
Title: Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
Journal: Geriatrics 20070501
Title: [How do medications used to treat urinary incontinence affect the cerebral function of the elderly?].
Journal: Der Urologe. Ausg. A 20070401
Title: [Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Journal: Der Urologe. Ausg. A 20070401
Title: Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes.
Journal: Current medical research and opinion 20070401
Title: Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Journal: The Annals of pharmacotherapy 20070301
Title: Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test.
Journal: European journal of pharmacology 20070227
Title: Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Journal: Biological & pharmaceutical bulletin 20070101
Title: Redefining response in overactive bladder syndrome.
Journal: BJU international 20070101
Title: Pharmacokinetics, safety, and tolerability of solifenacin in patients with renal insufficiency.
Journal: Journal of pharmacological sciences 20070101
Title: Identification of the patient with enlarged prostate: diagnosis and guidelines for management.
Journal: Osteopathic medicine and primary care 20070101
Title: [Solifenacin in the treatment of patients with hyperactive urinary bladder].
Journal: Urologiia (Moscow, Russia : 1999) 20070101
Title: [A placebo-controlled, double-blind, randomized trial of single daily dose of anti-muscarinic drug solifenacin succinate in patients with overactive bladder].
Journal: Akusherstvo i ginekologiia 20070101
Title: Application of evidence-based urology in improving quality of care.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: Newer agents for the management of overactive bladder.
Journal: American family physician 20061215
Title: Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder.
Journal: Expert opinion on pharmacotherapy 20061201
Title: Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder.
Journal: Pharmacotherapy 20061201
Title: [Pharmacological and clinical profile of solifenacin succinate (Vesicare) developed as a new therapeutic agent for overactive bladder].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20061201
Title: Open-label study of the safety and pharmacokinetics of solifenacin in subjects with hepatic impairment.
Journal: Journal of pharmacological sciences 20061201
Title: Solifenacin succinate (VESIcare): overactive bladder therapy.
Journal: Urologic nursing 20061201
Title: New developments in the treatment of urinary incontinence.
Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20061201
Title: Treatment of overactive bladder in the aging population: focus on darifenacin.
Journal: Clinical interventions in aging 20061201
Title: Solifenacin.
Journal: The Urologic clinics of North America 20061101
Title: Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20061101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20061101
Title: Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Journal: Clinical therapeutics 20061101
Title: Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.
Journal: The Cochrane database of systematic reviews 20061018
Title: Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.
Journal: International urogynecology journal and pelvic floor dysfunction 20060901
Title: Solifenacin succinate for the treatment of symptoms of overactive bladder.
Journal: Clinical therapeutics 20060901
Title: Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: A pooled analysis.
Journal: The American journal of geriatric pharmacotherapy 20060901
Title: Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
Journal: British journal of clinical pharmacology 20060801
Title: Solifenacin significantly improves all symptoms of overactive bladder syndrome.
Journal: International journal of clinical practice 20060801
Title: Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
Journal: Urology 20060801
Title: [Oral anticholinergics in overactive bladder].
Journal: Der Urologe. Ausg. A 20060701
Title: [Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Journal: Der Urologe. Ausg. A 20060701
Title: Comparative evaluation of exocrine muscarinic receptor binding characteristics and inhibition of salivation of solifenacin in mice.
Journal: Biological & pharmaceutical bulletin 20060701
Title: Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers.
Journal: Basic & clinical pharmacology & toxicology 20060701
Title: Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence.
Journal: International urogynecology journal and pelvic floor dysfunction 20060601
Title: Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
Journal: BJU international 20060601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060501
Title: The causes and consequences of overactive bladder.
Journal: Journal of women's health (2002) 20060401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060401
Title: Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
Journal: The American journal of medicine 20060301
Title: Pharmacologic management of overactive bladder: practical options for the primary care physician.
Journal: The American journal of medicine 20060301
Title: Management of overactive bladder and urge urinary incontinence in the elderly patient.
Journal: The American journal of medicine 20060301
Title: The emergence of new drugs for overactive bladder.
Journal: Expert opinion on emerging drugs 20060301
Title: Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Journal: The American journal of geriatric pharmacotherapy 20060301
Title: New drugs 06, part I.
Journal: Nursing 20060201
Title: Muscarinic receptors in the bladder: from basic research to therapeutics.
Journal: British journal of pharmacology 20060201
Title: Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005;48:464-70.
Journal: European urology 20060101
Title: Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.
Journal: Current medical research and opinion 20060101
Title: Solifenacin in overactive bladder syndrome.
Journal: Drugs 20060101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060101
Title: Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
Journal: Current urology reports 20051101
Title: The Q-T interval and antimuscarinic drugs.
Journal: Current urology reports 20051101
Title: [Drug discovery in the fields of urology: tamsulosin and solifenacin].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20051101
Title: Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Journal: Journal of medicinal chemistry 20051020
Title: Solifenacin in the management of the overactive bladder syndrome.
Journal: International journal of clinical practice 20051001
Title: A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.
Journal: European urology 20050901
Title: Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis.
Journal: European urology 20050901
Title: Role of muscarinic receptor antagonists in urgency and nocturia.
Journal: BJU international 20050901
Title: Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: a double-blind, placebo-controlled study.
Journal: Clinical therapeutics 20050901
Title: Solifenacin and darifenacin for overactive bladder.
Journal: Obstetrics and gynecology 20050801
Title: Darifenacin in the treatment of overactive bladder.
Journal: International journal of clinical practice 20050701
Title: New treatment options for overactive bladder.
Journal: South Dakota journal of medicine 20050601
Title: Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence.
Journal: Therapeutics and clinical risk management 20050601
Title: Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Journal: British journal of pharmacology 20050501
Title: Effect of age on the pharmacokinetics of solifenacin in men and women.
Journal: International journal of clinical pharmacology and therapeutics 20050501
Title: Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Journal: European journal of pharmacology 20050404
Title: Solifenacin and darifenacin for overactive bladder.
Journal: The Medical letter on drugs and therapeutics 20050314
Title: Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
Journal: European urology 20050301
Title: [Medical therapy of urinary incontinence].
Journal: Der Internist 20050101
Title: Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
Journal: BJU international 20050101
Title: New molecular entity: Vesicare, Yamanouchi/GlaxoSmithKline solifenacin.
Journal: Geriatrics 20050101
Title: New drugs: acamprosate calcium and solifenacin succinate.
Journal: Journal of the American Pharmacists Association : JAPhA 20050101
Title: Recent developments in the management of overactive bladder: focus on the efficacy and tolerability of once daily solifenacin succinate 5 mg.
Journal: Current medical research and opinion 20050101
Title: Improving the tolerability of anticholinergic agents in the treatment of overactive bladder.
Journal: Drug safety 20050101
Title: [Neurological aspect of the hyperactive urinary bladder syndrome].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
Title: Overactive bladder in the elderly: a guide to pharmacological management.
Journal: Drugs & aging 20050101
Title: Solifenacin in overactive bladder syndrome.
Journal: Drugs & aging 20050101
Title: Solifenacin in overactive bladder syndrome: a viewpoint by Scott Serels.
Journal: Drugs & aging 20050101
Title: Solifenacin in overactive bladder: a viewpoint by Hashim Hashim.
Journal: Drugs & aging 20050101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20041201
Title: Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder.
Journal: The Journal of urology 20041101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20041101
Title: The emerging role of solifenacin in the treatment of overactive bladder.
Journal: Expert opinion on investigational drugs 20041001
Title: Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine.
Journal: Current urology reports 20041001
Title: Elevating our therapeutic expectations in overactive bladder.
Journal: Journal of the American Academy of Nurse Practitioners 20041001
Title: Pharmacokinetics and safety of solifenacin succinate in healthy young men.
Journal: Journal of clinical pharmacology 20040901
Title: [Overactive bladder. New anticholinergic drug controls urinary urge].
Journal: MMW Fortschritte der Medizin 20040708
Title: Food does not affect the pharmacokinetics of solifenacin, a new muscarinic receptor antagonist: results of a randomized crossover trial.
Journal: British journal of clinical pharmacology 20040701
Title: [In overactive bladder, above all urgency is stressful. The patients know the site of each toilet].
Journal: MMW Fortschritte der Medizin 20040527
Title: In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
Journal: European journal of pharmacology 20040525
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040501
Title: Drug forecast--solifenacin: an investigational anticholinergic for overactive bladder.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20040501
Title: Solifenacin: treatment of overactive bladder.
Journal: Drugs of today (Barcelona, Spain : 1998) 20040401
Title: Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children.
Journal: Urology 20040301
Title: Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
Journal: BJU international 20040201
Title: Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.
Journal: Life sciences 20040102
Title: Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.
Journal: BJU international 20040101
Title: Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.
Journal: Drugs 20040101
Title: Solifenacin demonstrates high absolute bioavailability in healthy men.
Journal: Drugs in R&D 20040101
Title: [Urinary incontinence: anticholinergic treatment].
Journal: Revista de medicina de la Universidad de Navarra 20040101
Title: [Urinary incontinence: new pharmacologic therapies].
Journal: Revista de medicina de la Universidad de Navarra 20040101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20031101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030101
Title: M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20020801
Title: Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo.
Journal: Japanese journal of pharmacology 20010701
Title: Ikeda K, et al. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn Schmiedebergs Arch Pharmacol. 2002 Aug;366(2):97-103.
Title: Suzuki M, et al. Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarctedrats. Eur J Pharmacol. 2005 Apr 4;512(1):61-6.
